Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;40(5):871-877.
doi: 10.5535/arm.2016.40.5.871. Epub 2016 Oct 31.

Effectiveness of Lower Energy Density Extracorporeal Shock Wave Therapy in the Early Stage of Avascular Necrosis of the Femoral Head

Affiliations

Effectiveness of Lower Energy Density Extracorporeal Shock Wave Therapy in the Early Stage of Avascular Necrosis of the Femoral Head

Yong Han et al. Ann Rehabil Med. 2016 Oct.

Erratum in

Abstract

Objective: To evaluate the effectiveness of lower energy flux density (EFD) extracorporeal shock wave therapy (ESWT) in the early stage of avascular necrosis (AVN) of the femoral head.

Methods: Nineteen patients and 30 hips were enrolled. All subjects received 4 weekly sessions of ESWT, at different energy levels; group A (n=15; 1,000 shocks/session, EFD per shock 0.12 mJ/mm2) and group B (n=15; 1,000 shocks/session, EFD per shock 0.32 mJ/mm2). We measured pain by using the visual analog scale (VAS), and disability by using the Harris hip score, Hip dysfunction and Osteoarthritis Outcome Score (HOOS), and the Western Ontario and McMaster University Osteoarthritis Index (WOMAC). To determine the effect of the lower EFD ESWT, we assessed the VAS, Harris hip score, HOOS, WOMAC of the subjects before and at 1, 3, and 6 months.

Results: In both groups, the VAS, Harris hip score, HOOS, and WOMAC scores improved over time (p<0.05).

Conclusion: Lower EFD ESWT may be an effective method to improve the function and to relieve pain in the early stage of AVN.

Keywords: Disability evaluation; Femoral head necrosis; High-energy shock waves; Treatment outcome.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1. A flow diagram, showing the treatment process and assessment. ESWT, extracorporeal shock wave therapy; EFD, energy flux density.
Fig. 2
Fig. 2. The visual analogue scale (VAS) score at baseline and at 1-, 3-, and 6-month follow-ups after extracorporeal shock wave therapy in both groups. This figure shows significant improvement in the VAS score in both groups, for the entire period (*p<0.05 for time effect, *p<0.05 for group-time interaction). Group A, 0.12 mJ/mm2 energy group; group B, 0.32 mJ/mm2 energy group.
Fig. 3
Fig. 3. The Harris hip (HH) score at baseline and at 1-, 3-, and 6-month follow-ups after extracorporeal shock wave therapy in both groups. This figure shows significant improvement in the HH score in both groups, for the entire period (*p<0.05 for time effect, *p<0.05 for group-time interaction). Group A, 0.12 mJ/mm2 energy group; group B, 0.32 mJ/mm2 energy group.
Fig. 4
Fig. 4. The Hip dysfunction and Osteoarthritis Outcome Score (HOOS) score at baseline and at 1-, 3-, and 6-month follow-ups after extracorporeal shock wave therapy in both groups. This figure shows significant improvement in the HOOS score in both groups, for entire period (*p<0.05 for time effect, *p<0.05 for group-time interaction). Group A, 0.12 mJ/mm2 energy group; group B, 0.32 mJ/mm2 energy group.
Fig. 5
Fig. 5. The Western Ontario and McMaster University Osteoarthritis Index (WOMAC) score at baseline and at 1-, 3-, and 6-month follow-ups after extracorporeal shock wave therapy in both groups. This figure shows significant improvement in the WOMAC score in both groups, for entire period (*p<0.05 for time effect, *p<0.05 for group-time interaction). Group A, 0.12 mJ/mm2 energy group; group B, 0.32 mJ/mm2 energy group.

References

    1. Wang CJ, Cheng JH, Huang CC, Yip HK, Russo S. Extracorporeal shockwave therapy for avascular necrosis of femoral head. Int J Surg. 2015;24(Pt B):184–187. - PubMed
    1. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32:94–124. - PubMed
    1. Mont MA, Carbone JJ, Fairbank AC. Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res. 1996;(324):169–178. - PubMed
    1. Wong T, Wang CJ, Hsu SL, Chou WY, Lin PC, Huang CC. Cocktail therapy for hip necrosis in SARS patients. Chang Gung Med J. 2008;31:546–553. - PubMed
    1. Revell P. Book review: Bone circulation and vascularization in normal and pathological conditions. J Anat. 1994;184(Pt 2):429.

LinkOut - more resources